Selskabets formål er at udvikle, importere, producere, forhandle og eksportere lægemidler samt anden dermed i naturlig forbindelse stående virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 52.4 mio. | 11.2 mio. | 115.2 mio. | 49.9 mio. | 29 | |
CVR: 36960566
Secondary names: 2care4. ApS, AFORTAS ApS
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Erik Sandberg joined as ADM. DIR.
Ulrik Ernst Rasmussen left as ADM. DIR.
Henrik Bisgaard Jensen left the board
Thomas Hjarsbæk Rasmussen left as director
Companies in the same industry and area
companydata.dk